Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129201) titled 'Obinutuzumab beta Combined with Glucocorticoids for the Treatment of ANCA-associated Glomerulonephritis: A Pilot Clinical Trial' on July 31.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Elderly ANCA-associated glomerulonephritis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Study group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=334055
Published by HT Digital Content Services with permission from Health Dail...